Show simple item record

dc.contributor.advisorShaw, William W.en_US
dc.contributor.authorCarrizosa, Santiago, 1964-
dc.creatorCarrizosa, Santiago, 1964-en_US
dc.date.accessioned2013-04-18T09:36:14Z
dc.date.available2013-04-18T09:36:14Z
dc.date.issued1996en_US
dc.identifier.urihttp://hdl.handle.net/10150/282221
dc.description.abstractFor several decades, pharmaceutical companies have engaged in bioprospecting activities in developing countries. However, in many cases, these companies have failed to compensate local peoples for their knowledge used in the production of drugs. Consequently, these activities have been subject to intense scrutiny at the national and international level. This awareness has contributed to the elaboration of international laws and novel bioprospecting initiatives. The Convention on Biological Diversity (CBD), laws that regulate access to genetic resources, and the International Cooperative Biodiversity Groups (ICBGs) are approaches that address unique issues pertaining to bioprospecting of genetic resources. However, these approaches are not flawless. They are experiments that need to be tested and analyzed. The main objectives of this dissertation are to: (1) analyze the relationship between these approaches and how they address the issue of bioprospecting; and (2) identify bioprospecting guidelines to facilitate the implementation of future bioprospecting projects. These objectives are addressed through the analysis of a conceptual framework for the implementation of the ICBGs. According to this framework implementation of the ICBGs should be made according to the following four factors: (1) the CBD, (2) contractual relationships between parties of bioprospecting groups, (3) contractual provisions of bioprospecting agreements, and (4) in-country laws, policies and the organizational structure of the government. These factors have and will continue to affect the implementation of the ICBGs and other bioprospecting groups. A thorough analysis of them in the context of the ICBGs and in comparison to other projects provides elements for the identification of valuable lessons for future bioprospecting initiatives.
dc.language.isoen_USen_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.subjectChemistry, Pharmaceutical.en_US
dc.subjectPolitical Science, General.en_US
dc.subjectPolitical Science, International Law and Relations.en_US
dc.titleProspecting for biodiversity: The search for legal and institutional frameworksen_US
dc.typetexten_US
dc.typeDissertation-Reproduction (electronic)en_US
thesis.degree.grantorUniversity of Arizonaen_US
thesis.degree.leveldoctoralen_US
dc.identifier.proquest9720602en_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.disciplineRenewable Natural Resourcesen_US
thesis.degree.namePh.D.en_US
dc.identifier.bibrecord.b34528386en_US
refterms.dateFOA2018-08-16T02:55:56Z
html.description.abstractFor several decades, pharmaceutical companies have engaged in bioprospecting activities in developing countries. However, in many cases, these companies have failed to compensate local peoples for their knowledge used in the production of drugs. Consequently, these activities have been subject to intense scrutiny at the national and international level. This awareness has contributed to the elaboration of international laws and novel bioprospecting initiatives. The Convention on Biological Diversity (CBD), laws that regulate access to genetic resources, and the International Cooperative Biodiversity Groups (ICBGs) are approaches that address unique issues pertaining to bioprospecting of genetic resources. However, these approaches are not flawless. They are experiments that need to be tested and analyzed. The main objectives of this dissertation are to: (1) analyze the relationship between these approaches and how they address the issue of bioprospecting; and (2) identify bioprospecting guidelines to facilitate the implementation of future bioprospecting projects. These objectives are addressed through the analysis of a conceptual framework for the implementation of the ICBGs. According to this framework implementation of the ICBGs should be made according to the following four factors: (1) the CBD, (2) contractual relationships between parties of bioprospecting groups, (3) contractual provisions of bioprospecting agreements, and (4) in-country laws, policies and the organizational structure of the government. These factors have and will continue to affect the implementation of the ICBGs and other bioprospecting groups. A thorough analysis of them in the context of the ICBGs and in comparison to other projects provides elements for the identification of valuable lessons for future bioprospecting initiatives.


Files in this item

Thumbnail
Name:
azu_td_9720602_sip1_m.pdf
Size:
6.484Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record